Vor Biopharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2026 | 5.67 M | $104.44 M | 0.00% | 10.45% |
| FMR LLC | 08/13/2026 | 4.93 M | $90.80 M | 220.34% | 9.08% |
| FCPM III SERVICES B.V. | 08/14/2026 | 4.12 M | $75.80 M | 0.00% | 7.58% |
| BLACKROCK, INC. | 08/07/2026 | 3.47 M | $63.85 M | 336.37% | 6.39% |
| VENROCK ADVISER, LLC | 08/14/2026 | 3.04 M | $56.00 M | 0.00% | 5.60% |
| STATE STREET CORP | 09/22/2026 | 2.62 M | $48.17 M | 133.92% | 4.82% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 2.54 M | $46.83 M | 0.00% | 4.68% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 2.40 M | $44.22 M | -55.56% | 4.42% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.08 M | $38.37 M | 45.42% | 3.84% |
| CALIGAN PARTNERS LP | 08/14/2026 | 1.93 M | $35.44 M | 0.00% | 3.55% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2026 | 1.75 M | $32.22 M | 0.00% | 3.22% |
| GREAT POINT PARTNERS LLC | 08/14/2026 | 1.70 M | $31.30 M | -2.86% | 3.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.06 M | $19.56 M | 210.14% | 1.96% |
| NEXTBIO CAPITAL MANAGEMENT LP | 08/14/2026 | 889.16 K | $16.37 M | -11.08% | 1.64% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 845.00 K | $15.56 M | 100.00% | 1.56% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 680.63 K | $12.53 M | 100.00% | 1.25% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 650.00 K | $11.97 M | -13.33% | 1.20% |
| ROSALIND ADVISORS, INC. | 08/14/2026 | 648.60 K | $11.94 M | -7.34% | 1.19% |
| NAN FUNG TRINITY (HK) LTD | 07/24/2026 | 646.55 K | $11.90 M | 100.00% | 1.19% |
| BRAIDWELL LP | 08/14/2026 | 573.10 K | $10.55 M | 22.78% | 1.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 558.70 K | $10.29 M | 0.54% | 1.03% |
| UBS GROUP AG | 08/13/2026 | 493.28 K | $9.08 M | 1.01% | 0.91% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 428.07 K | $7.88 M | 65.54% | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2026 | 416.42 K | $7.67 M | 29.36% | 0.77% |
| WOODLINE PARTNERS LP | 08/14/2026 | 379.72 K | $6.99 M | 100.00% | 0.70% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 340.36 K | $6.27 M | 100.00% | 0.63% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 328.89 K | $6.05 M | 25.58% | 0.61% |
| NORTHERN TRUST CORP | 08/13/2026 | 328.74 K | $6.05 M | 409.29% | 0.61% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 300.70 K | $5.54 M | 62.10% | 0.55% |
| CLEARLINE CAPITAL LP | 08/14/2026 | 285.28 K | $5.25 M | -12.54% | 0.53% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 177.74 K | $3.27 M | 57.44% | 0.33% |
| CITADEL ADVISORS LLC | 09/02/2026 | 160.41 K | $2.95 M | 7.83% | 0.30% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 149.68 K | $2.76 M | 100.00% | 0.28% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 121.40 K | $2.23 M | 446.44% | 0.22% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 121.40 K | $2.23 M | 100.00% | 0.22% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 97.72 K | $1.80 M | 100.00% | 0.18% |
| MARSHALL WACE, LLP | 08/13/2026 | 95.64 K | $1.76 M | -91.71% | 0.18% |
| NUVEEN, LLC | 08/11/2026 | 94.82 K | $1.75 M | 100.00% | 0.17% |
| AXIOM INVESTORS LLC /DE | 08/12/2026 | 92.11 K | $1.70 M | -3.80% | 0.17% |
| XTX TOPCO LTD | 08/14/2026 | 82.65 K | $1.52 M | 100.00% | 0.15% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 70.89 K | $1.31 M | -59.03% | 0.13% |
| INVESCO LTD. | 08/14/2026 | 68.30 K | $1.26 M | 488.80% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 64.60 K | $1.19 M | -63.34% | 0.12% |
| CITIGROUP INC | 08/03/2026 | 63.13 K | $1.16 M | 1,074.95% | 0.12% |
| MORGAN STANLEY | 08/13/2026 | 61.56 K | $1.13 M | -47.26% | 0.11% |
| RHUMBLINE ADVISERS | 08/12/2026 | 57.53 K | $1.06 M | 100.00% | 0.11% |
| ALPS ADVISORS INC | 07/29/2026 | 55.00 K | $1.01 M | 100.00% | 0.10% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 54.67 K | $1.01 M | 100.00% | 0.10% |
| JOHNSON & JOHNSON | 08/06/2026 | 53.73 K | $989.21 K | 0.00% | 0.10% |
| RAFFERTY ASSET MANAGEMENT, LLC | 08/14/2026 | 48.82 K | $898.74 K | -3.34% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vor Biopharma Inc institutional Ownership - FAQ's
During the previous two years, 145 institutional investors and hedge funds held shares of Vor Biopharma Inc. The most heavily invested institutionals were:
ALPS ADVISORS INC: 78,371
JOHNSON & JOHNSON: 53,732
STRS OHIO: 47,400
CITIGROUP INC: 22,564
PROFUND ADVISORS LLC: 16,811
Creative Planning: 11,586
89.55% of Vor Biopharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 52.66 M shares in the last 24 months. This purchase volume represents approximately $814.14 M in transactions.